Huaren Pharmaceutical Co (SZSE:300110) 3-Year EBITDA Growth Rate : 21.00% (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Huaren Pharmaceutical Co 3-Year EBITDA Growth Rate?

Huaren Pharmaceutical Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.06.

During the past 12 months, Huaren Pharmaceutical Co's average EBITDA Per Share Growth Rate was 7.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 21.00% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 19.10% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 6.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Huaren Pharmaceutical Co was 26.30% per year. The lowest was -10.20% per year. And the median was 9.50% per year.

Competitive Comparison of Huaren Pharmaceutical Co's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Huaren Pharmaceutical Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Huaren Pharmaceutical Co's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Huaren Pharmaceutical Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Huaren Pharmaceutical Co's 3-Year EBITDA Growth Rate falls into.

Huaren Pharmaceutical Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Huaren Pharmaceutical Co (SZSE:300110) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Huaren Pharmaceutical Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Huaren Pharmaceutical Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Huaren Pharmaceutical Co (SZSE:300110) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Huaren Pharmaceutical Co Ltd (SZSE:300110) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

No. 187 Zhuzhou Road, Qingdao, Shandong, CHN, 266100

Website

http://www.qdhuaren.com

Huaren Pharmaceutical Co Ltd is a China-based company engaged in the manufacture, and sale of non-polyvinyl chloride and Non-PVC large capacity preparations. Its categories of products include conventional infusion, therapy infusion, and nutrition infusion. The company distributes its products in domestic market, with Northeast China as its main market.

Executives

Yang Xiao Dong	Director
Bo Guo Xiu	Executives
Zhou Xi Jian	Director
Mao Yu Wei	Supervisors
Chu Xiao Jun	Executives
Zhou Qiang	Directors, executives
Ji Sheng Bin	Executives
Xiao Wei Wen	Executives
Shen Hong Ce	Executives
Li Xiao Li	Executives
Liu Qian	Executives
Wang Wen Ping	Executives
Liang Fu You	Director
Liang Fu Dong	Director
Gong Ling	Secretary Dong

Huaren Pharmaceutical Co (SZSE:300110) Headlines

No Headlines